SCHEMBL7128352

SCHEMBL7128352

O=C(Nc1cccc(-c2ccccc2)c1)c1cc([N+](=O)[O-])ccc1Cl

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RORC P51449 9/20 0.81
SMN1; SMN2 Q16637 4/20 0.81
PPARG P37231 4/20 0.81
MAPK1 P28482 3/20 0.81
MEN1 O00255 2/20 0.81
KMT2A Q03164 2/20 0.81
CYP3A4 P08684 2/20 0.81
LMNA P02545 1/20 0.81
TP53 P04637 1/20 0.81
CYP1A2 P05177 1/20 0.81
CYP2D6 P10635 1/20 0.81
MAPT P10636 1/20 0.81
CYP2C9 P11712 1/20 0.81
PKM P14618 1/20 0.81
TSHR P16473 1/20 0.81
NFKB1 P19838 1/20 0.81
CYP2C19 P33261 1/20 0.81
THPO P40225 1/20 0.81
MTOR P42345 1/20 0.81
PMP22 Q01453 1/20 0.81

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7125062 0.90 RORC (0.85) RORCSMN1; SMN2PPARGMAPK1MEN1
SCHEMBL29369092 0.90 RORC (1.00) RORCSMN1; SMN2PPARGMAPK1MEN1
SCHEMBL420231 0.90 RORC (1.00) RORCSMN1; SMN2PPARGMAPK1MEN1
SCHEMBL7130551 0.89 RORC (0.82) RORCSMN1; SMN2PPARGMAPK1MEN1
SCHEMBL7120914 0.87 RORC (0.83) RORCSMN1; SMN2PPARGMAPK1MEN1
SCHEMBL18147368 0.86 RORC (0.78) RORCSMN1; SMN2PPARGMAPK1MEN1
SCHEMBL7122886 0.85 RORC (0.77) RORCSMN1; SMN2PPARGMAPK1MEN1
SCHEMBL7120440 0.85 SMN1; SMN2 (0.81) RORCSMN1; SMN2PPARGMAPK1MEN1
SCHEMBL7122936 0.85 RORC (0.80) RORCSMN1; SMN2PPARGMAPK1MEN1
SCHEMBL7121705 0.84 RORC (0.80) RORCSMN1; SMN2PPARGMAPK1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030134859-A1 PPAR-gamma modulator SANKYO COMPANY, LIMITED (JP) 2003-07-17 US disclosed
EP-1277729-A1 PPAR (GAMMA) MODULATORS Sankyo Company, Limited (JP) 2003-01-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030134859-A1 PPAR-gamma modulator PPARG, PPARA, PPARD RORC 67/4885SMN1; SMN2 3743/4885PPARG 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.